kallikreins - CISMeF

Preferred Label : kallikreins;

MeSH definition : Proteolytic enzymes from the serine endopeptidase family found in normal blood and urine. Specifically, Kallikreins are potent vasodilators and hypotensives and increase vascular permeability and affect smooth muscle. They act as infertility agents in men. Three forms are recognized, PLASMA KALLIKREIN (EC 3.4.21.34), TISSUE KALLIKREIN (EC 3.4.21.35), and PROSTATE-SPECIFIC ANTIGEN (EC 3.4.21.77).;

MeSH synonym : callicrein; kallikrein; kalliginogenase; kininogenase; kallidinogenase; kinin-forming enzyme; enzyme, kinin-forming; kinin forming enzyme;

MeSH hyponym : padutin; kallikrein B'; beta-Kallikrein B; dilminal; alpha-Kallikrein; beta-Kallikrein; kallikrein A; kallikrein light chain; Light Chain, Kallikrein; beta Kallikrein; beta Kallikrein B; alpha Kallikrein;

MeSH Related Number : 9001-01-8 (kallidinogenase);

Registry Number MeSH : EC 3.4.21.-;

MeSH annotation : /antag permitted but consider KALLIKREIN-TRYPSIN INACTIVATOR;

Wikipedia link : https://en.wikipedia.org/wiki/Kallikrein;

Codes EINECS : 232-574-5;

Is substance : O;

Details

Origin ID

D007610;

UMLS CUI

C0022478;

ATC code(s)
- kallidinogenase [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Kallikrein [LOINC component]
- Kallikrein [NCIt concept]
- Kallikrein (substance) [SNOMED CT concept]
- kallikrein [Substance BNPC]
- kallikrein [SNOMED Notion]
Indexing information
- 4-(beta-amidinoethenyl)phenyl-4-guanidinobenzoate dimethanesulfonate [MeSH Supplementary Concept]
- 4-amidino-2-benzoylphenyl 4-guanidinobenzoate dimethanesulfonate [MeSH Supplementary Concept]
- 4-aminomethylcyclohexanecarbonyl-O-2-bromobenzyloxycarbonyltyrosine 4-acetylanilide [MeSH Supplementary Concept]
- BbKI protein, bauhinia bauhinioides [MeSH Supplementary Concept]
- CH 694 [MeSH Supplementary Concept]
- KKI 5 [MeSH Supplementary Concept]
- KKI 7 [MeSH Supplementary Concept]
- KKI 8 [MeSH Supplementary Concept]
- PKSI 1007 [MeSH Supplementary Concept]
- PKSI 527 [MeSH Supplementary Concept]
- aprotinin, desprolyl(2)-arginyl(15)- [MeSH Supplementary Concept]
- benzoyl-prolyl-phenylalanyl-boroarginine [MeSH Supplementary Concept]
- benzoyl-prolyl-phenylalanyl-boroarginine [MeSH Supplementary Concept]
- ecallantide [MeSH Supplementary Concept]
- isoleucyl-phenylalanyl-arginine chloromethyl ketone [MeSH Supplementary Concept]
- isoleucyl-phenylalanyl-lysine chloromethyl ketone [MeSH Supplementary Concept]
- kallikrein-like protein 18 [MeSH Supplementary Concept]
- kallistatin [MeSH Supplementary Concept]
- nafamostat [MeSH Supplementary Concept]
- phenylalanyl-phenylalanyl-arginine chloromethyl ketone [MeSH Supplementary Concept]
- prolyl-phenylalanyl-Aph-seryl-valyl-glycinamide [MeSH Supplementary Concept]
Pharmacological action(s)
- coagulants [MeSH Descriptor]
- fertility agents, male [MeSH Descriptor]
- reproductive control agents [MeSH Descriptor]
Record concept(s)
- alpha-Kallikrein [MeSH concept]
- beta-Kallikrein [MeSH concept]
- beta-Kallikrein B [MeSH concept]
- dilminal [MeSH concept]
- kallikrein A [MeSH concept]
- kallikrein B' [MeSH concept]
- kallikrein light chain [MeSH concept]
- kallikreins [MeSH concept]
- padutin [MeSH concept]
Related MeSH Supplementary Concept(s)
- AHP-Ka, agkistrodon halys pallas [MeSH Supplementary Concept]
- DM199 [MeSH Supplementary Concept]
- KLK10 protein, human [MeSH Supplementary Concept]
- KLK12 protein, human [MeSH Supplementary Concept]
- KLK13 protein, human [MeSH Supplementary Concept]
- KLK14 protein, human [MeSH Supplementary Concept]
- KLK15 protein, human [MeSH Supplementary Concept]
- KLK2 protein, human [MeSH Supplementary Concept]
- KLK3 protein, human [MeSH Supplementary Concept]
- KLK4-205, human [MeSH Supplementary Concept]
- KLK5 protein, human [MeSH Supplementary Concept]
- KLK6 protein, human [MeSH Supplementary Concept]
- KLK7 protein, human [MeSH Supplementary Concept]
- KLK7 protein, rat [MeSH Supplementary Concept]
- KLK8 protein, human [MeSH Supplementary Concept]
- KLK9 protein, human [MeSH Supplementary Concept]
- KLKB1 protein, human [MeSH Supplementary Concept]
- Klk10 protein, mouse [MeSH Supplementary Concept]
- Klk13 protein, mouse [MeSH Supplementary Concept]
- Klk15 protein, mouse [MeSH Supplementary Concept]
- Klk1b22 protein, mouse [MeSH Supplementary Concept]
- Klk26 protein, mouse [MeSH Supplementary Concept]
- Klk27 protein, mouse [MeSH Supplementary Concept]
- Klk5 protein, mouse [MeSH Supplementary Concept]
- Klk7 protein, mouse [MeSH Supplementary Concept]
- Klk9 protein, mouse [MeSH Supplementary Concept]
- Nico-Padutin [MeSH Supplementary Concept]
- Prss18 protein, mouse [MeSH Supplementary Concept]
- Prss19 protein, mouse [MeSH Supplementary Concept]
- T-kininogenase, antigen gamma light chain protein, rat [MeSH Supplementary Concept]
- alpha 2-macroglobulin-kallikrein complex [MeSH Supplementary Concept]
- angiotrofin [MeSH Supplementary Concept]
- benzoylkallikrein [MeSH Supplementary Concept]
- blarinasin protein, blarina brevicauda [MeSH Supplementary Concept]
- epidermal growth factor binding protein, mouse [MeSH Supplementary Concept]
- kallikrein (11-23) [MeSH Supplementary Concept]
- kallikrein (328-343) [MeSH Supplementary Concept]
- kallikrein 1b22, mouse [MeSH Supplementary Concept]
- kallikrein 21, mouse [MeSH Supplementary Concept]
- kallikrein 24, mouse [MeSH Supplementary Concept]
- kallikrein 4 [MeSH Supplementary Concept]
- kallikrein Klk21 [MeSH Supplementary Concept]
- kallikrein, decreased urinary activity of [MeSH Supplementary Concept]
- kallikrein-like protein S3 [MeSH Supplementary Concept]
- ornithokallikrein [MeSH Supplementary Concept]
- prokallikrein, tissue [MeSH Supplementary Concept]
- proteinase D [MeSH Supplementary Concept]
- proteinase P [MeSH Supplementary Concept]
See also
- coagulants [MeSH Descriptor]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Enzyme [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Kallidinogenase [NCIt concept]
- Kallikrein [ICD-11 Extension code]
- Kallikrein [NCIt concept]
- Kallikrein [LOINC component]
- Kallikrein (substance) [SNOMED CT concept]
- kallidinogenase [ATC Code]
- kallikrein [Substance BNPC]
- kallikrein [SNOMED Notion]
Validated automatic mappings to BTNT
- Kallidinogenase [ICD-11 Extension code]
- Kallikrein [ICD-11 Extension code]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients